472 related articles for article (PubMed ID: 18984420)
1. Therapeutic potential for B-cell modulation in Sjögren's syndrome.
Mariette X
Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420
[TBL] [Abstract][Full Text] [Related]
2. B cell-targeted therapies in Sjögren's syndrome.
Tobón GJ; Pers JO; Youinou P; Saraux A
Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
[TBL] [Abstract][Full Text] [Related]
3. Immune regulation and B-cell depletion therapy in patients with primary Sjögren's syndrome.
Abdulahad WH; Kroese FG; Vissink A; Bootsma H
J Autoimmun; 2012 Aug; 39(1-2):103-11. PubMed ID: 22341852
[TBL] [Abstract][Full Text] [Related]
4. An important role for B-cell activation factor and B cells in the pathogenesis of Sjögren's syndrome.
Mackay F; Groom JR; Tangye SG
Curr Opin Rheumatol; 2007 Sep; 19(5):406-13. PubMed ID: 17762603
[TBL] [Abstract][Full Text] [Related]
5. Emerging biotherapies for Sjögren's syndrome.
Tobón GJ; Saraux A; Pers JO; Youinou P
Expert Opin Emerg Drugs; 2010 Jun; 15(2):269-82. PubMed ID: 20384543
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy in primary Sjögren's syndrome.
Alcântara C; Gomes MJ; Ferreira C
Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
[TBL] [Abstract][Full Text] [Related]
7. Polarization of B effector cells in Sjögren's syndrome.
Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of Sjögren's syndrome and therapeutic consequences.
Mariette X; Gottenberg JE
Curr Opin Rheumatol; 2010 Sep; 22(5):471-7. PubMed ID: 20671520
[TBL] [Abstract][Full Text] [Related]
9. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
Guzman Moreno R
Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
[TBL] [Abstract][Full Text] [Related]
10. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
11. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
He J; Zhao JX; Wang H; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):625-9. PubMed ID: 18646720
[TBL] [Abstract][Full Text] [Related]
12. [B lymphocytes in Sjögren's syndrome].
Pers JO; Le Pottier L; Devauchelle V; Saraux A; Youinou P
Rev Med Interne; 2008 Dec; 29(12):1000-6. PubMed ID: 18403061
[TBL] [Abstract][Full Text] [Related]
13. [Immunopathology of Gougerot-Sjogren syndrome].
Youinou P; Mariette X
Rev Prat; 2001 Jan; 51(2):165-70. PubMed ID: 11252942
[TBL] [Abstract][Full Text] [Related]
14. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.
Saraux A
Autoimmun Rev; 2010 Jul; 9(9):609-14. PubMed ID: 20452466
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Arthritis Rheum; 2001 Feb; 44(2):490. PubMed ID: 11229485
[No Abstract] [Full Text] [Related]
16. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome: a quintessential B cell-induced autoimmune disease.
Youinou P
Joint Bone Spine; 2008 Jan; 75(1):1-2. PubMed ID: 17905630
[No Abstract] [Full Text] [Related]
18. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
19. B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment.
Cornec D; Devauchelle-Pensec V; Tobón GJ; Pers JO; Jousse-Joulin S; Saraux A
J Autoimmun; 2012 Sep; 39(3):161-7. PubMed ID: 22749831
[TBL] [Abstract][Full Text] [Related]
20. Identification of transitional type II B cells in the salivary glands of patients with Sjögren's syndrome.
Daridon C; Pers JO; Devauchelle V; Martins-Carvalho C; Hutin P; Pennec YL; Saraux A; Youinou P
Arthritis Rheum; 2006 Jul; 54(7):2280-8. PubMed ID: 16802367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]